Xiaoyuan Bian
State Key Laboratory of Diagnosis and Treatment of Infectious Diseases
ORCID: 0000-0002-7275-3103- Papers in database
- 7
- Primary author
- 1 paper
- Years active
- 2018 – 2021
- Health outcomes studied
- 7
Health Outcomes Studied
Papers (7)
- 2021Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats.10.1039/d0fo02530e
- 2021Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI0110.1007/s00253-021-11099-z
- 2020Primary authorPediococcus pentosaceus LI05 alleviates DSS‐induced colitis by modulating immunological profiles, the gut microbiota and short‐chain fatty acid levels in a mouse model10.1111/1751-7915.13583
- 2020New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism10.3748/wjg.v26.i40.6224
- 2020Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice10.1007/s00253-020-10621-z
- 2019Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats10.1007/s00253-019-10211-8
- 2018Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats10.1007/s00253-018-9454-y